Technical Use of Angiotensin I/II (1-5) in RAS Research

What This Product Solves

Angiotensin I/II (1-5) is a standardized pentapeptide (Asp-Arg-Val-Tyr-Ile) fragment derived from the enzymatic cleavage of angiotensin I and II. As a defined blood pressure regulation peptide, it enables researchers to model the downstream effects of the renin-angiotensin system (RAS), particularly in studies focused on vasoconstriction and aldosterone release stimulation. The peptide’s precise sequence and solid formulation ensure experimental reproducibility in cardiovascular and renal research. Its utility is limited to workflows requiring explicit control of angiotensin-derived peptide concentrations and signaling, avoiding confounding variables present in complex biological extracts (product_spec).

Related internal guidance, such as Technical Use of Angiotensin I/II (1-5) in RAS Research, further clarifies the peptide’s application in cardiovascular and renal physiology, providing workflow-specific recommendations.

Protocol Parameters

• Solvent Preparation | DMSO (≥66.5 mg/mL) or ethanol (≥69.5 mg/mL) | Required for solution-phase workflows and stock preparation | Ensures complete dissolution of the peptide for accurate dosing and reproducibility; water insolubility precludes aqueous preparations | product_spec
• Storage Condition | -20°C (solid state) | All long-term storage and batch stability workflows | Maintains molecular integrity and prevents degradation over time; critical for multi-batch or time-course studies | product_spec
• Model System Use | Cardiovascular/renal cell lines or ex vivo tissue | Application in hypertension research, blood pressure regulation, and aldosterone release stimulation | The peptide’s mechanistic role is specifically relevant to RAS-related signaling; not appropriate for unrelated peptide or signaling studies | workflow_recommendation

Workflow Setup and QC Checklist

• Solubilization: Weigh Angiotensin I/II (1-5) accurately and dissolve in DMSO or ethanol to generate a concentrated stock. Avoid water-based solvents due to insolubility (product_spec).
• Aliquoting: Prepare single-use aliquots to prevent repeated freeze-thaw cycles, which may compromise peptide stability.
• Storage: Store all solid and solution stocks at -20°C. For any working solutions, minimize time at room temperature to reduce risk of degradation.
• Application: Use only in protocols modeling the renin-angiotensin system, such as angiotensin-converting enzyme substrate assays, vasoconstrictor peptide fragment signaling, or aldosterone release stimulation workflows.
• QC Confirmation: Confirm peptide identity and purity by analytical HPLC or mass spectrometry prior to experimental use, if facility resources permit.
• For further procedural detail, see Practical Use of Angiotensin I/II (1-5) in RAS Research, which expands on handling and application specifics in peptide hormone vasoconstriction models.

Common Failure Modes and Fixes

• Incomplete Dissolution: If undissolved material remains after vortexing in DMSO or ethanol, increase solvent volume incrementally and apply gentle sonication. Do not attempt dissolution in water.
• Peptide Degradation: Avoid repeated freeze-thaw cycles by aliquoting stock solutions. If degradation is suspected (e.g., loss of activity), verify by HPLC or mass spectrometry and prepare fresh aliquots from solid stock.
• Off-target Effects: Restrict use to cardiovascular or renal workflows; do not introduce Angiotensin I/II (1-5) into unrelated cell signaling assays, as specificity is sequence and context dependent.
• Precipitation in Aqueous Media: If precipitation occurs upon dilution in aqueous buffers, maintain final DMSO or ethanol concentration within cell/tissue tolerance limits, or consider pre-mixing with compatible protein carriers if appropriate for the assay.

Scope and Limitations

• This peptide is validated only for research on RAS-driven processes, such as blood pressure regulation, aldosterone release, and related cardiovascular signaling (product_spec).
• Its use outside these domains (e.g., general peptide hormone studies, unrelated signal transduction pathways) is not supported and may yield uninterpretable results (internal_article).
• The peptide’s water insolubility imposes workflow constraints, necessitating organic solvent use throughout handling and application.
• No direct paper references are available for this specific product; all recommendations derive from product specification and internal workflow guidance.

Conclusion

Angiotensin I/II (1-5) serves as a standardized Asp-Arg-Val-Tyr-Ile peptide for precise modeling of the renin-angiotensin system in hypertension and renal research. Its technical value lies in its defined composition, enabling controlled investigation of blood pressure regulation and aldosterone release mechanisms. Proper solubilization in DMSO or ethanol, strict adherence to -20°C storage, and workflow restriction to cardiovascular and renal models are essential for reproducibility and data integrity. For additional product details, consult the Angiotensin I/II (1-5) page on APExBIO.